Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design and synthesis of novel pyridopyrimidine derivatives with anchoring non-coplanar aromatic extensions of EGFR inhibitory activity
Amal A.M. Eissa, Kholoud F.M. Aljamal, Hany S. Ibrahim, et al.
Bioorganic Chemistry (2021) Vol. 116, pp. 105318-105318
Closed Access | Times Cited: 18

Showing 18 citing articles:

New thiazole-based derivatives as EGFR/HER2 and DHFR inhibitors: Synthesis, molecular modeling simulations and anticancer activity
Mohamed Sabry, Mariam A. Ghaly, Azza R. Maarouf, et al.
European Journal of Medicinal Chemistry (2022) Vol. 241, pp. 114661-114661
Closed Access | Times Cited: 40
Harnessing molecular hybridization approach to discover novel quinoline EGFR-TK inhibitors for cancer treatment
Noha Ryad, Ayman Abo Elmaaty, Ibrahim M. Ibrahim, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 11, pp. 1087-1107
Closed Access | Times Cited: 5
Epidermal Growth Factor Receptors Unveiled: A Comprehensive Survey on Mutations, Clinical Insights of Global Inhibitors, and Emergence of Heterocyclic Derivatives as EGFR Inhibitors
Chandramouli Manojmouli, T. Y. Pasha, Mohamed Rahamathulla, et al.
Journal of drug targeting (2025), pp. 1-19
Closed Access
Synthetic strategies of heterocycle-integrated pyridopyrimidine scaffolds supported by nano-catalysts
Mohamed M. Hammouda, Marwa M. Rashed, Khaled M. Elattar, et al.
RSC Advances (2023) Vol. 13, Iss. 17, pp. 11600-11634
Open Access | Times Cited: 11
EGFR as therapeutic target to develop new generation tyrosine kinase inhibitors against breast cancer: A critical review
Ruby Mariam Raju, Jeffin Joy A, Raghavendra Nulgumnalli Manjunathaiah, et al.
Results in Chemistry (2024) Vol. 7, pp. 101490-101490
Open Access | Times Cited: 3
Insights into the effect of elaborating coumarin-based aryl enaminones with sulfonamide or carboxylic acid functionality on carbonic anhydrase inhibitory potency and selectivity
Hany S. Ibrahim, Mohamed A. Abdelrahman, Alessio Nocentini, et al.
Bioorganic Chemistry (2022) Vol. 126, pp. 105888-105888
Closed Access | Times Cited: 17
Modified pyrido[2,3-d]pyrimidin-4(3H)-one derivatives as EGFRWT and EGFRT790M inhibitors: Design, synthesis, and anti-cancer evaluation
Eman S. Nossier, Rania A. Alasfoury, Mohamed Hagras, et al.
Journal of Molecular Structure (2022) Vol. 1270, pp. 133971-133971
Closed Access | Times Cited: 16
An Appraisal on Synthetic and Medicinal Aspects of Fused Pyrimidines as Anti Neoplastic Agents
Isha Rani, Navgeet Kaur, Anju Goyal, et al.
Anti-Cancer Agents in Medicinal Chemistry (2022) Vol. 23, Iss. 5, pp. 525-561
Closed Access | Times Cited: 13
Design and synthesis of some new 6-bromo-2-(pyridin-3-yl)-4-substituted quinazolines as multi tyrosine kinase inhibitors
Ahmed K.B.A.W. Farouk, Heba Abdelrasheed Allam, Essam Rashwan, et al.
Bioorganic Chemistry (2022) Vol. 128, pp. 106099-106099
Closed Access | Times Cited: 12
Synthesis, molecular modeling Insights, and anticancer assessment of novel polyfunctionalized Pyridine congeners
Mohamed G. Abouelenein, Ahmed A. El‐Rashedy, Hanem M. Awad, et al.
Bioorganic Chemistry (2023) Vol. 141, pp. 106910-106910
Closed Access | Times Cited: 6
Novel oxadiazole functionalized pyridopyrimidine derivatives; their anticancer activity and molecular docking studies
Raghu Dasari, Srinivas Gali, Rajashekar Korra, et al.
Journal of Heterocyclic Chemistry (2024) Vol. 61, Iss. 4, pp. 642-650
Open Access | Times Cited: 1
Efficient synthetic strategies for fused pyrimidine and pyridine derivatives: A review
Sharmil N. Anjirwala, Saurabh K. Patel
Journal of Heterocyclic Chemistry (2024) Vol. 61, Iss. 10, pp. 1481-1516
Closed Access | Times Cited: 1
Molecular Docking Studies, Antiproliferative Evaluation, and Synthesis of 7-(1H-Indol-3-yl)pyrido[2,3-d]pyrimidine Derivatives
Mohamed A. A. Radwan, Osamah Al Rugaie, Waleed Al Abdulmonem, et al.
Russian Journal of Bioorganic Chemistry (2022) Vol. 48, Iss. 4, pp. 809-820
Closed Access | Times Cited: 4
Synthesis, Biological Evaluation, DNA Binding, and Molecular Docking of Hybrid 4,6-Dihydrazone Pyrimidine Derivatives as Antitumor Agents
Hai-Rong Lan, Junying Song, Juan Yuan, et al.
Molecules (2022) Vol. 28, Iss. 1, pp. 187-187
Open Access | Times Cited: 4
New pyridopyrimidine derivatives as dual EGFR and CDK4/cyclin D1 inhibitors: synthesis, biological screening and molecular modeling
Fatma MA Krakisha, Dina I. A. Othman, Walaa M El Husseiny, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 16, pp. 1633-1648
Closed Access
Design and synthesis of novel 2-(2-(4-bromophenyl)quinolin-4-yl)-1,3,4-oxadiazole derivatives as anticancer and antimicrobial candidates: in vitro and in silico studies
Noha Ryad, Ayman Abo Elmaaty, Samy Selim, et al.
RSC Advances (2024) Vol. 14, Iss. 46, pp. 34005-34026
Open Access
Synthesis and Reactions of 2-Amino-3-Cyanopyridine Derivatives (A Review)
Kurls E. Anwer, G. H. SAYED
Russian Journal of Organic Chemistry (2024) Vol. 60, Iss. 11, pp. 2170-2227
Closed Access
Six-membered ring systems: pyridines and benzo derivatives
Jeanese C. Badenock
Progress in heterocyclic chemistry (2023), pp. 387-424
Closed Access
Page 1

Scroll to top